What are the major opportunities in the Type 2 Diabetes market? What are the strategies for the Type 2 Diabetes market?

For detailed insights on the major opportunities and strategies in the Type 2 Diabetes market, Read More

How does the Type 2 Diabetes market relate to the overall economy and other similar markets?

For detailed insights on Type 2 Diabetes's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Type 2 Diabetes market growth? SWOT analysis of the Type 2 Diabetes market.

For detailed insights on the key dynamics influencing the Type 2 Diabetes market growth and SWOT analysis of the Type 2 Diabetes industry, Read More

Type 2 Diabetes Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Type 2 Diabetes Market Report 2026

Name: Type 2 Diabetes Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Class (Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas And Insulin Secretagogues, Biguanides, SodiumGlucose Cotransporter 2 Inhibitors, Other Drug Classes), By Application (Glycemic Control, Cardiovascular Safety, Hypoglycemia Avoidance, Other Applications), By End-User (Children, Adults) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Type 2 Diabetes Market Overview

• Type 2 Diabetes market size has reached to $51.47 billion in 2025

• Expected to grow to $78.67 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%

• Growth Driver: Elevated Rates Of Obesity And Heart Disease Fuel Expansion Of The Type 2 Diabetes Market

• Market Trend: Innovative Products Like Mounjaro Revolutionize The Type 2 Diabetes Market For Enhanced Patient Care

• North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Type 2 Diabetes Market?

Type 2 diabetes is a chronic metabolic disorder characterized by elevated blood sugar levels due to insulin resistance and inadequate insulin production. The development of Type 2 diabetes is influenced by a combination of genetic, lifestyle and environmental factors. Dietary and pharmaceutical adjustments can manage type 2 diabetes by lowering weight, eating a healthy diet and exercising consistently.

The main types of drug classes in type 2 diabetes are dipeptidyl peptide-4 (DPP-4) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, thiazolidinediones, alpha-glucosidase inhibitors, sulfonylureas and other insulin secretagogues, biguanides, sodiumglucose cotransporter 2 inhibitors and others. Dipeptidyl peptidase-4 (DPP-4) inhibitors refer to a class of oral medications that work by blocking the enzyme responsible for breaking down incretin hormones, which help regulate blood sugar levels. They are used for several applications, including glycemic control, cardiovascular safety, hypoglycemia avoidance and others by targeting various end-users, such as children and adults.

Type 2 Diabetes Market Global Report 2026 Market Report bar graph

What Is The Type 2 Diabetes Market Size and Share 2026?

The type 2 diabetes market size has grown strongly in recent years. It will grow from $51.47 billion in 2025 to $55.53 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to rising global obesity prevalence, increased sedentary lifestyles, expansion of oral antidiabetic drug availability, growing screening for metabolic disorders, improved access to primary diabetes care.

What Is The Type 2 Diabetes Market Growth Forecast?

The type 2 diabetes market size is expected to see strong growth in the next few years. It will grow to $78.67 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for weight-management focused therapies, rising adoption of personalized diabetes treatment plans, expansion of digital therapeutic platforms, growing focus on preventive diabetes management, increasing investments in next-generation antidiabetic drugs. Major trends in the forecast period include increasing adoption of glp-1 receptor agonists, rising focus on cardiometabolic risk management, growing use of combination drug therapies, expansion of lifestyle-integrated treatment approaches, enhanced emphasis on long-term glycemic control.

Book your 30 minutes free consultation with our research experts

Global Type 2 Diabetes Market Segmentation

1) By Drug Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas And Insulin Secretagogues, Biguanides, SodiumGlucose Cotransporter 2 Inhibitors, Other Drug Classes

2) By Application: Glycemic Control, Cardiovascular Safety, Hypoglycemia Avoidance, Other Applications

3) By End-User: Children, Adults

Subsegments:

1) By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin

2) By Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Liraglutide, Semaglutide, Dulaglutide, Exenatide

3) By Thiazolidinediones: Pioglitazone, Rosiglitazone

4) By Alpha-Glucosidase Inhibitors: Acarbose, Miglitol

5) By Sulfonylureas And Insulin Secretagogues: Glimepiride, Glipizide, Glyburide

6) By Biguanides: Metformin, Buformin, Phenformin

7) By Sodium-Glucose Cotransporter 2 Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin

8) By Other Drug Classes: Amylin Analogues, Bile Acid Sequestrants, Dopamine Agonists

What Is The Driver Of The Type 2 Diabetes Market?

Increasing rates of obesity and heart disease are expected to propel the growth of the type 2 diabetes market going forward. Obesity is a medical condition where excess body fat has accumulated to an unhealthy level, while heart disease refers to a range of conditions that affect the heart and blood vessels. Excess body weight increases the risk of insulin resistance, leading to high blood sugar levels and the development of type 2 diabetes. In contrast, high blood sugar levels can damage blood vessels and nerves that control the heart and blood vessels, leading to heart disease. For instance, in March 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that approximately one in eight people worldwide were struggling with obesity. This included 2.5 billion adults (aged 18 years and older) who were overweight, with 890 million of them living with obesity. Among adults, 43% were overweight, and 16% were classified as obese. Additionally, the number of overweight children under the age of 5 reached 37 million. Therefore, rising rates of obesity and heart disease are driving the growth of the type 2 diabetes industry.

Key Players In The Global Type 2 Diabetes Market

Major companies operating in the type 2 diabetes market are F. Hoffmann-La Roche AG, Merck and Co. Inc, Novartis AG, AstraZeneca plc, Abbott Laboratories, Sanofi SA, Medtronic plc, Takeda Pharmaceutical Company, GlaxoSmithKline plc, Eli Lilly and Company, Novo Nordisk A/S, Johnson And Johnson Private Limited, Daiichi Sankyo Co. Ltd, Boehringer Ingelheim International GmbH, Dexcom Inc, Amgen Inc., Insulet Corporation, Ascensia Diabetes Care, Beta Bionics, Onduo LLC, DarioHealth, One Drop, Bigfoot Biomedical Inc., Digbi Health, MySugr GmbH, Senseonics Holdings Inc., Provention Bio Inc., Vida Health Inc., Diathrive Health

Global Type 2 Diabetes Market Trends and Insights

Major companies operating in the type 2 diabetes market are focusing on developing advanced solutions, such as extended-indication SGLT2/GLP-1 combination therapies, to deliver enhanced glycemic control, reduce comorbidities, and improve patient adherence. Extended-indication SGLT2/GLP-1 combination therapies refer to pharmaceutical regimens that combine sodium-glucose co-transporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists (or their fixed-dose combinations) to simultaneously target blood glucose regulation, obesity, cardiovascular and renal outcomes in patients with type 2 diabetes. For instance, in June 2024, AstraZeneca, a UK-based pharmaceutical company, received U.S. FDA approval for Farxiga (dapagliflozin) for the paediatric type 2 diabetes indication (age 10 years and older), expanding usage beyond adult populations and signalling a broader patient-base strategy. This innovation offers once-daily oral dosing in younger patients, integrated cardiometabolic and renal protection data, and market expansion into paediatric and early-stage type 2 diabetes segments, driving growth in the global type 2 diabetes market.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Type 2 Diabetes Market?

In January 2024, Roche Group, a Switzerland-based healthcare company, acquired Carmot Therapeutics for an undisclosed amount. Roche obtains access to Carmot’s current R&D portfolio including all clinical and pre-clinical assets, as well as exclusive access to Carmot’s innovative Chemotype Evolution discovery platform in metabolism, further strengthening Roche’s R&D efforts and portfolio across cardiovascular and metabolic diseases. Carmot Therapeutics is a clinical-stage biotechnology company that is focused on advancing life-changing therapeutics for people with obesity and diabetes.

Regional Outlook

North America was the largest region in the type 2 diabetes market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Type 2 Diabetes Market?

The type 2 diabetes market consists of revenues earned by entities by providing services such as blood sugar monitoring, diabetes education and support, bariatric surgery and lifestyle modifications. The market value includes the value of related goods sold by the service provider or included within the service offering. The type 2 diabetes market also includes sales of blood glucose meters, insulin pens, insulin syringes, insulin pumps, metformin and diabetic socks. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Type 2 Diabetes Market Report 2026?

The type 2 diabetes market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the type 2 diabetes industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Type 2 Diabetes Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$55.53 billion
Revenue Forecast In 2035	$78.67 billion
Growth Rate	CAGR of 7.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Class, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche AG, Merck and Co. Inc, Novartis AG, AstraZeneca plc, Abbott Laboratories, Sanofi SA, Medtronic plc, Takeda Pharmaceutical Company, GlaxoSmithKline plc, Eli Lilly and Company, Novo Nordisk A/S, Johnson And Johnson Private Limited, Daiichi Sankyo Co. Ltd, Boehringer Ingelheim International GmbH, Dexcom Inc, Amgen Inc., Insulet Corporation, Ascensia Diabetes Care, Beta Bionics, Onduo LLC, DarioHealth, One Drop, Bigfoot Biomedical Inc., Digbi Health, MySugr GmbH, Senseonics Holdings Inc., Provention Bio Inc., Vida Health Inc., Diathrive Health
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Type 2 Diabetes Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Type 2 Diabetes Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Type 2 Diabetes Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Type 2 Diabetes Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Glp-1 Receptor Agonists

4.2.2 Rising Focus On Cardiometabolic Risk Management

4.2.3 Growing Use Of Combination Drug Therapies

4.2.4 Expansion Of Lifestyle-Integrated Treatment Approaches

4.2.5 Enhanced Emphasis On Long-Term Glycemic Control

5. Type 2 Diabetes Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Retail Pharmacies

5.4 Specialty Diabetes Centers

5.5 Home Care Providers

6. Type 2 Diabetes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Type 2 Diabetes Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Type 2 Diabetes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Type 2 Diabetes Market Size, Comparisons And Growth Rate Analysis

7.3. Global Type 2 Diabetes Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Type 2 Diabetes Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Type 2 Diabetes Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Type 2 Diabetes Market Segmentation

9.1. Global Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas And Insulin Secretagogues, Biguanides, Sodium-Glucose Cotransporter 2 Inhibitors, Other Drug Classes

9.2. Global Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Glycemic Control, Cardiovascular Safety, Hypoglycemia Avoidance, Other Applications

9.3. Global Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Children, Adults

9.4. Global Type 2 Diabetes Market, Sub-Segmentation Of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sitagliptin, Saxagliptin, Linagliptin, Alogliptin

9.5. Global Type 2 Diabetes Market, Sub-Segmentation Of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Liraglutide, Semaglutide, Dulaglutide, Exenatide

9.6. Global Type 2 Diabetes Market, Sub-Segmentation Of Thiazolidinediones, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pioglitazone, Rosiglitazone

9.7. Global Type 2 Diabetes Market, Sub-Segmentation Of Alpha-Glucosidase Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Acarbose, Miglitol

9.8. Global Type 2 Diabetes Market, Sub-Segmentation Of Sulfonylureas And Insulin Secretagogues, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Glimepiride, Glipizide, Glyburide

9.9. Global Type 2 Diabetes Market, Sub-Segmentation Of Biguanides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Metformin, Buformin, Phenformin

9.10. Global Type 2 Diabetes Market, Sub-Segmentation Of Sodium-Glucose Cotransporter 2 Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Canagliflozin, Dapagliflozin, Empagliflozin

9.11. Global Type 2 Diabetes Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Amylin Analogues, Bile Acid Sequestrants, Dopamine Agonists

10. Type 2 Diabetes Market Regional And Country Analysis

10.1. Global Type 2 Diabetes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Type 2 Diabetes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Type 2 Diabetes Market

11.1. Asia-Pacific Type 2 Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Type 2 Diabetes Market

12.1. China Type 2 Diabetes Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Type 2 Diabetes Market

13.1. India Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Type 2 Diabetes Market

14.1. Japan Type 2 Diabetes Market Overview

14.2. Japan Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Type 2 Diabetes Market

15.1. Australia Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Type 2 Diabetes Market

16.1. Indonesia Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Type 2 Diabetes Market

17.1. South Korea Type 2 Diabetes Market Overview

17.2. South Korea Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Type 2 Diabetes Market

18.1. Taiwan Type 2 Diabetes Market Overview

18.2. Taiwan Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Type 2 Diabetes Market

19.1. South East Asia Type 2 Diabetes Market Overview

19.2. South East Asia Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Type 2 Diabetes Market

20.1. Western Europe Type 2 Diabetes Market Overview

20.2. Western Europe Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Type 2 Diabetes Market

21.1. UK Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Type 2 Diabetes Market

22.1. Germany Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Type 2 Diabetes Market

23.1. France Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Type 2 Diabetes Market

24.1. Italy Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Type 2 Diabetes Market

25.1. Spain Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Type 2 Diabetes Market

26.1. Eastern Europe Type 2 Diabetes Market Overview

26.2. Eastern Europe Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Type 2 Diabetes Market

27.1. Russia Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Type 2 Diabetes Market

28.1. North America Type 2 Diabetes Market Overview

28.2. North America Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Type 2 Diabetes Market

29.1. USA Type 2 Diabetes Market Overview

29.2. USA Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Type 2 Diabetes Market

30.1. Canada Type 2 Diabetes Market Overview

30.2. Canada Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Type 2 Diabetes Market

31.1. South America Type 2 Diabetes Market Overview

31.2. South America Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Type 2 Diabetes Market

32.1. Brazil Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Type 2 Diabetes Market

33.1. Middle East Type 2 Diabetes Market Overview

33.2. Middle East Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Type 2 Diabetes Market

34.1. Africa Type 2 Diabetes Market Overview

34.2. Africa Type 2 Diabetes Market, Segmentation By Drug Class, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Type 2 Diabetes Market Regulatory and Investment Landscape

36. Type 2 Diabetes Market Competitive Landscape And Company Profiles

36.1. Type 2 Diabetes Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Type 2 Diabetes Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Type 2 Diabetes Market Company Profiles

36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck and Co. Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

37. Type 2 Diabetes Market Other Major And Innovative Companies

Sanofi SA, Medtronic plc, Takeda Pharmaceutical Company, GlaxoSmithKline plc, Eli Lilly and Company, Novo Nordisk A/S, Johnson And Johnson Private Limited, Daiichi Sankyo Co. Ltd, Boehringer Ingelheim International GmbH, Dexcom Inc, Amgen Inc., Insulet Corporation, Ascensia Diabetes Care, Beta Bionics, Onduo LLC

38. Global Type 2 Diabetes Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Type 2 Diabetes Market

40. Type 2 Diabetes Market High Potential Countries, Segments and Strategies

40.1 Type 2 Diabetes Market In 2030 - Countries Offering Most New Opportunities

40.2 Type 2 Diabetes Market In 2030 - Segments Offering Most New Opportunities

40.3 Type 2 Diabetes Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Type 2 Diabetes Market, Overview Of Key Products - Product Examples

Table 2: Global Type 2 Diabetes Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Type 2 Diabetes Market, Supply Chain Analysis

Table 4: Global Type 2 Diabetes Market, Major Raw Material Providers

Table 5: Global Type 2 Diabetes Market, Major Resource Providers

Table 6: Global Type 2 Diabetes Market, Major Manufacturers (Suppliers)

Table 7: Global Type 2 Diabetes Market, Major Distributors And Channel Partners

Table 8: Global Type 2 Diabetes Market, Key Technologies & Future Trends

Table 9: Global Type 2 Diabetes Market, Major Trends

Table 10: Global Type 2 Diabetes Market, Major End Users

Table 11: Global Type 2 Diabetes Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Type 2 Diabetes Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Type 2 Diabetes Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Type 2 Diabetes Market - TAM, US$ Billion, 2025

Table 15: Global Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Type 2 Diabetes Market, Sub-Segmentation Of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Type 2 Diabetes Market, Sub-Segmentation Of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Type 2 Diabetes Market, Sub-Segmentation Of Thiazolidinediones, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Type 2 Diabetes Market, Sub-Segmentation Of Alpha-Glucosidase Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Type 2 Diabetes Market, Sub-Segmentation Of Sulfonylureas And Insulin Secretagogues, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Type 2 Diabetes Market, Sub-Segmentation Of Biguanides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Type 2 Diabetes Market, Sub-Segmentation Of Sodium-Glucose Cotransporter 2 Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Type 2 Diabetes Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Type 2 Diabetes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Global Type 2 Diabetes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Asia-Pacific, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: China, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: India, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Japan, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Australia, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Indonesia, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South Korea, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Taiwan, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: South East Asia, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Western Europe, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: UK, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Germany, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: France, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Italy, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Spain, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Eastern Europe, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: Russia, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: North America, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: USA, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Canada, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: South America, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Brazil, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Middle East, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Africa, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 100: Global Type 2 Diabetes Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 101: Global Type 2 Diabetes Market - Company Scoring Matrix

Table 102: F. Hoffmann-La Roche AG Financial Performance

Table 103: Merck and Co. Inc Financial Performance

Table 104: Novartis AG Financial Performance

Table 105: AstraZeneca plc Financial Performance

Table 106: Abbott Laboratories Financial Performance

Table 107: Global Type 2 Diabetes Market, Competitive Benchmarking (In USD Billions)

Table 108: Global Type 2 Diabetes Market, Competitive Dashboard

Table 109: Global Type 2 Diabetes Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 110: Global, Type 2 Diabetes Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 111: Global, Type 2 Diabetes Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 112: Global, Type 2 Diabetes Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Type 2 Diabetes Market, Overview Of Key Products - Product Examples

Figure 2: Global Type 2 Diabetes Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Type 2 Diabetes Market, Supply Chain Analysis

Figure 4: Global Type 2 Diabetes Market, Major Raw Material Providers

Figure 5: Global Type 2 Diabetes Market, Major Resource Providers

Figure 6: Global Type 2 Diabetes Market, Major Manufacturers (Suppliers)

Figure 7: Global Type 2 Diabetes Market, Major Distributors And Channel Partners

Figure 8: Global Type 2 Diabetes Market, Key Technologies & Future Trends

Figure 9: Global Type 2 Diabetes Market, Major Trends

Figure 10: Global Type 2 Diabetes Market, Major End Users

Figure 11: Global Type 2 Diabetes Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Type 2 Diabetes Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Type 2 Diabetes Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Type 2 Diabetes Market - TAM, US$ Billion, 2025

Figure 15: Global Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Type 2 Diabetes Market, Sub-Segmentation Of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Type 2 Diabetes Market, Sub-Segmentation Of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Type 2 Diabetes Market, Sub-Segmentation Of Thiazolidinediones, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Type 2 Diabetes Market, Sub-Segmentation Of Alpha-Glucosidase Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Type 2 Diabetes Market, Sub-Segmentation Of Sulfonylureas And Insulin Secretagogues, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Type 2 Diabetes Market, Sub-Segmentation Of Biguanides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Type 2 Diabetes Market, Sub-Segmentation Of Sodium-Glucose Cotransporter 2 Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Type 2 Diabetes Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Type 2 Diabetes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Global Type 2 Diabetes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Asia-Pacific, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: China, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: India, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Japan, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Australia, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Indonesia, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South Korea, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Taiwan, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: South East Asia, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Western Europe, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: UK, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Germany, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: France, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Italy, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Spain, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Eastern Europe, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: Russia, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: North America, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: USA, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Canada, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: South America, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Brazil, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Middle East, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Type 2 Diabetes Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Type 2 Diabetes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Africa, Type 2 Diabetes Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 100: Global Type 2 Diabetes Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 101: Global Type 2 Diabetes Market - Company Scoring Matrix

Figure 102: F. Hoffmann-La Roche AG Financial Performance

Figure 103: Merck and Co. Inc Financial Performance

Figure 104: Novartis AG Financial Performance

Figure 105: AstraZeneca plc Financial Performance

Figure 106: Abbott Laboratories Financial Performance

Figure 107: Global Type 2 Diabetes Market, Competitive Benchmarking (In USD Billions)

Figure 108: Global Type 2 Diabetes Market, Competitive Dashboard

Figure 109: Global Type 2 Diabetes Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 110: Global, Type 2 Diabetes Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 111: Global, Type 2 Diabetes Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 112: Global, Type 2 Diabetes Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Global Outpatient Clinics Market Forecast to Reach $53.81 Billion by 2029, Driven by 5.3% CAGR

Outpatient Home Therapy Industry Poised for Rapid Expansion, Projected to Hit $72.97 Billion by 2029

In-Depth Outpatient Oncology Infusion Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Outpatient Rehabilitation Services Market

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Explore the latest trends, growth insights, and forecasts in the Global Wearable Fitness Trackers Market.

Insuman Market Report 2026 - Global Outlook – By Patient Demographics (Pediatric Patients, Adult Patients, Elderly Patients), By Distribution Channel (Hospitals, Retail Pharmacies, Specialty Pharmacies, Online Pharmacies...

Non-Insulin Therapies For Diabetes Market Report 2026 - Global Outlook – By Type (Biguanides, Sulfonylureas, Thiazolidinediones (TZDs), DPP 4 Inhibitors, GLP 1 Analogs Or Agonists, SGLT2 Inhibitors), By Route Of Administ...

Diabetes Pen Market Report 2026 - Global Outlook – By Product (Insulin Pens, Pen Needles), By Usage (Reusable Injection Pens, Disposable Injection Pens), By Therapy (Insulin, Glucagon-Like Peptide-1, Growth Hormones, Fer...

Diabetic Kidney Disease Market Report 2026 - Global Outlook – By Type (Type 1 Diabetes, Type 2 Diabetes), By Treatment (Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant In...

Type 2 Diabetes Market Report 2026 - Global Outlook – By Drug Class (Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfony...

Type 1 Diabetes Market Report 2026 - Global Outlook – By Product Type (Rapid Acting Insulin Analogs, Long-Acting Insulin Analogs, Premix Insulin Analogs, Others Product Types), By Device (Insulin Pump, Insulin Pen, Blood...

Antidiabetics Market Report 2026 - Global Outlook – By Drug Class (Insulin, GLP-1 Receptor Agonists, DPP- 4 Inhibitors, SGLT2 Inhibitors, Other Drug Classes), By Diabetes Type (Type 1, Type 2), By Patient Population (Ant...

Frequently Asked Questions

How big is the Type 2 Diabetes Market?

The Type 2 Diabetes market was valued at $51.47 billion in 2025, increased to $55.53 billion in 2026, and is projected to reach $78.67 billion by 2030. request a sample here

What is the Type 2 Diabetes market growth?

The global Type 2 Diabetes market is expected to grow at a CAGR of 9.1% from 2026 to 2035 to reach $78.67 billion by 2035. request a sample here

Who are the key players in Type 2 Diabetes market?

Some Key Players in the Type 2 Diabetes market Include, F. Hoffmann-La Roche AG, Merck and Co. Inc, Novartis AG, AstraZeneca plc, Abbott Laboratories, Sanofi SA, Medtronic plc, Takeda Pharmaceutical Company, GlaxoSmithKline plc, Eli Lilly and Company, Novo Nordisk A/S, Johnson And Johnson Private Limited, Daiichi Sankyo Co. Ltd, Boehringer Ingelheim International GmbH, Dexcom Inc, Amgen Inc., Insulet Corporation, Ascensia Diabetes Care, Beta Bionics, Onduo LLC, DarioHealth, One Drop, Bigfoot Biomedical Inc., Digbi Health, MySugr GmbH, Senseonics Holdings Inc., Provention Bio Inc., Vida Health Inc., Diathrive Health . request a sample here

What is the anticipated growth trend for the Type 2 Diabetes market?

Major trend in this market includes: Innovative Products Like Mounjaro Revolutionize The Type 2 Diabetes Market For Enhanced Patient Care. For further insights on this market. request a sample here

Which region has the most growth potential in the Type 2 Diabetes market?

North America was the largest region in the type 2 diabetes market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the type 2 diabetes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Type 2 Diabetes Market Report 2026 market?

Major companies operating in the Type 2 Diabetes Market Report 2026 market are Major companies operating in the type 2 diabetes market are F. Hoffmann-La Roche AG, Merck and Co. Inc, Novartis AG, AstraZeneca plc, Abbott Laboratories, Sanofi SA, Medtronic plc, Takeda Pharmaceutical Company, GlaxoSmithKline plc, Eli Lilly and Company, Novo Nordisk A/S, Johnson And Johnson Private Limited, Daiichi Sankyo Co. Ltd, Boehringer Ingelheim International GmbH, Dexcom Inc, Amgen Inc., Insulet Corporation, Ascensia Diabetes Care, Beta Bionics, Onduo LLC, DarioHealth, One Drop, Bigfoot Biomedical Inc., Digbi Health, MySugr GmbH, Senseonics Holdings Inc., Provention Bio Inc., Vida Health Inc., Diathrive Health request a sample here.

Which region has the most growth potential in the Type 2 Diabetes Market Report 2026 market?